Company
United StatesPublic company, NYSE: DALDelta Air Lines Inc (NYSE: DAL), Atlanta, GA – FDA Inspections
Inspection records and compliance data for Delta Air Lines Inc in Atlanta, Georgia. 2 FDA inspections on record, 1 Form 483, last inspected May 10, 2022. Publicly traded as NYSE: DAL.
Company Profile
This profile covers Delta Air Lines Inc based in Atlanta, Georgia, United States.
FDA Inspection History
- FDA inspections
- 2
- OAI
- 0
- VAI
- 1
- NAI
- 1
- Form 483s
- 1
- Warning letters
- 0
First inspected June 18, 2019. Last inspected May 10, 2022.
Most cited issue areas
- Develop FSVP1 inspection
FDA inspections (2)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| May 10, 2022 | NAI | Foods & Cosmetics · Foodborne Biological Hazards | 1178130 |
| June 18, 2019 | VAI | Foods & Cosmetics · Foodborne Biological Hazards | 1093316 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Delta Air Lines Inc
Stock ticker
DAL
Exchange
NYSE
Share price
$85.55
Market cap
$56.3B
Price as of
November 6, 2026
FEI Number
3001130630
Address
1010 Delta Blvd, Atlanta, Georgia 30354, United States
Country
United States
ID: 9c995a0e-2dc9-4b5d-a4cf-0e17150bca58